OverviewChartNewsTraderScreen

HSBC Knock-Out AMGN/  DE000TT3YEJ2  /

EUWAX
5/3/2024  7:43:37 PM Chg.+3.28 Bid8:09:45 PM Ask8:09:45 PM Underlying Strike price Expiration date Option type
9.09EUR +56.45% 8.95
Bid Size: 50,000		 8.97
Ask Size: 50,000		 Amgen Inc 215.8116 USD 12/31/2078 Call
TeleTrader 3:30 PM Wall Street surges on open as jobs report sparks rate cut hopes
TeleTrader 12:04 PM Amgen soars 14% on positive weight-loss drug data
TeleTrader 5/2 Amgen Q1 revenue jumps 22% to $7.4 billion
TeleTrader 5/2 US surges at close as traders weigh Fed remarks
TeleTrader 5/2 US opens higher, Dow jumps 240 points
GlobeNewswire 5/2 Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Canc...
TeleTrader 5/2 US higher premarket after Fed's decision
GlobeNewswire 5/1 Fight Colorectal Cancer Launches ChatCRC: An AI-Powered Chatbot Revolutionizing Colorectal Cancer Su...
GlobeNewswire 5/1 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...
GlobeNewswire 4/30 Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab bios...
GlobeNewswire 4/24 Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeti...
TeleTrader 4/24 Wall Street opens mostly higher amid earnings jitters
GlobeNewswire 4/23 Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...
GlobeNewswire 4/16 Turnstone Biologics Appoints William Waddill to its Board of Directors
GlobeNewswire 4/15 IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
GlobeNewswire 4/15 Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
GlobeNewswire 4/15 Shah Capital nominates two highly qualified independent director candidates for Novavax
GlobeNewswire 4/11 FundaMental Pharma appoints Dr. Dirk Beher as Chief Executive Officer
GlobeNewswire 4/9 Opthea Appoints John Han, PharmD, as VP Medical Affairs
GlobeNewswire 4/8 Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual ...
GlobeNewswire 4/8 CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated EpCAM-Dire...
GlobeNewswire 4/5 NeuroVigil, World’s Most Valuable Neurotech, Launches iBrain™ in US
GlobeNewswire 4/5 CORRECTION -- NeuroVigil, World’s Most Valuable Neurotech Company, Launches in US
GlobeNewswire 4/5 NeuroVigil, World’s Most Valuable Neurotech Company, Launches in US
GlobeNewswire 4/4 Over 52 Million Myeloma Warriors Reached, Creating Ripples Across the Globe for #MyelomaACTIONMonth